NEW YORK – Veritas Genetics is shutting down its US operations, at least temporarily, due to financial troubles.
Mirza Cifric, the company's CEO, told GenomeWeb that the firm ran out of funds because a planned financing fell through, which was "very abrupt and unexpected," and that it started laying off most of its US staff, more than 30 employees, earlier this week.